Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
23%
OVERLAP
BY WEIGHT
19
# OF OVERLAPPING
HOLDINGS
SBIO
80
HOLDINGS
27%
ALSO IN BBP
BBP
67
HOLDINGS
31%
ALSO IN SBIO
SECTOR DRIFT (SBIO minus BBP)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in SBIO |
Weight in BBP |
Overlap | |
|---|---|---|---|---|
| AMICUS THERAPEUTICS INC | 2.8% | 2.1% | 2.1% | |
| MIRUM PHARMACEUTICALS, INC. | 2.8% | 1.9% | 1.9% | |
| TRAVERE THERAPEUTICS, INC. | 2.0% | 1.7% | 1.7% | |
| NUVATION BIO INC CLASS A | 1.8% | 1.7% | 1.7% | |
| TARSUS PHARMACEUTICALS, INC. | 2.1% | 1.6% | 1.6% | |
SBIO Overweight Relative to BBP
| KYMERA THERAPEUTICS, INC. | 3.8% | |
| CELCUITY INC. | 3.2% | |
| ALKERMES PLC | 3.1% | |
| CG ONCOLOGY, INC. | 2.8% | |
| APOGEE THERAPEUTICS, INC. | 2.7% | |
| VIKING THERAPEUTICS, INC. | 2.3% | |
| IDEAYA BIOSCIENCES, INC. | 2.1% | |
| VERA THERAPEUTICS, INC. CLASS A | 2.0% | |
| DISC MEDICINE, INC. | 1.9% | |
| CRINETICS PHARMACEUTICALS INC | 1.8% |
SBIO Underweight Relative to BBP
| IOVANCE BIOTHERAPEUTICS INC | -1.9% | |
| AXSOME THERAPEUTICS, INC. | -1.9% | |
| PHATHOM PHARMACEUTICALS, INC. | -1.8% | |
| BIOMARIN PHARMACEUTICAL INC | -1.7% | |
| HALOZYME THERAPEUTICS INC | -1.7% | |
| EXELIXIS INC | -1.7% | |
| REGENERON PHARMACEUTICALS | -1.6% | |
| INCYTE CORP | -1.6% | |
| AMGEN INC | -1.6% | |
| SYNDAX PHARMACEUTICALS INC | -1.6% |